PspA and PspC: Their Potential for Use as Pneumococcal Vaccines
- 1 January 1997
- news
- Published by Mary Ann Liebert Inc
- Vol. 3 (4), 401-408
- https://doi.org/10.1089/mdr.1997.3.401
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.Keywords
This publication has 54 references indexed in Scilit:
- Systemic and Mucosal Protective Immunity to Pneumococcal Surface Protein AAnnals of the New York Academy of Sciences, 1996
- The Repertoire of Human Antibodies to the Carbohydrate Capsule of Streptococcus pneumoniae 6BThe Journal of Infectious Diseases, 1996
- PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in miceVaccine, 1996
- The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniaeTrends in Microbiology, 1996
- Truncated Streptococcus pneumoniae PspA Molecules Elicit Cross-Protective Immunity against Pneumococcal Challenge in MiceThe Journal of Infectious Diseases, 1996
- Pathogenesis of Pneumococcal InfectionNew England Journal of Medicine, 1995
- Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).The Journal of Experimental Medicine, 1987
- Potential for intravenous gamma-globulin use in neonatal gram-negative infectionThe Pediatric Infectious Disease Journal, 1986
- Capsular Antigens Noncovalently or Covalently Associated with Protein as Vaccines to Haemophilus influenzae Type b: Comparison in Two-Year-Old ChildrenThe Journal of Infectious Diseases, 1985
- Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.The Journal of Experimental Medicine, 1984